3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Gastrointestinal
152
Lymphoid
19
Thoracic
11
Other solid neoplasm
8
Gynecologic
8
Genitourinary
5
Tumor-Agnostic
4
Other hematologic neoplasm
3
Head & Neck
3
Sarcoma
2
Dermatologic
2
CNS
2
Breast
2
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
14
lutetium Lu 177 dotatate
13
Nivolumab
11
cabozantinib
10
Everolimus
9
pembrolizumab
8
gallium Ga 68 dotatate
7
Ipilimumab
6
Cisplatin
6
Carboplatin
6
Etoposide
5
trametinib
4
olaparib
4
lenvatinib
4
X-Rays
4
Lutetium-177
4
CTLA-4 Antigen
4
fluorodopa F 18
3
dabrafenib
3
cemiplimab
3
Surveys and Questionnaires
3
Phantoms, Imaging
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Blood Specimen Collection
3
177Lu-octreotide, DOTA(0)-Tyr(3)-
3
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oxaliplatin
×
Endocrine
×
90 days
×
Clear all
No trials found.